M&A and consolidation on rising trend in bio industry.

Published: 2001-12-17 06:58:00

Updated: 2001-12-17 06:58:00

Recently the company organization enlargement and the company consolidation among the same business entities showed an ongoing stance in the world bio-engineering industry led by the United States while the number and size of the M&A slightly declined. The M&A with the pharmaceutical firms declin...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK